These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37821007)

  • 1. European nanomaterial legislation in the past 20 years - Closing the final gaps.
    Nielsen MB; Skjolding L; Baun A; Hansen SF
    NanoImpact; 2023 Oct; 32():100487. PubMed ID: 37821007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Considerations on the EU definition of a nanomaterial: science to support policy making.
    Bleeker EA; de Jong WH; Geertsma RE; Groenewold M; Heugens EH; Koers-Jacquemijns M; van de Meent D; Popma JR; Rietveld AG; Wijnhoven SW; Cassee FR; Oomen AG
    Regul Toxicol Pharmacol; 2013 Feb; 65(1):119-25. PubMed ID: 23200793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory landscape of nanotechnology and nanoplastics from a global perspective.
    Allan J; Belz S; Hoeveler A; Hugas M; Okuda H; Patri A; Rauscher H; Silva P; Slikker W; Sokull-Kluettgen B; Tong W; Anklam E
    Regul Toxicol Pharmacol; 2021 Jun; 122():104885. PubMed ID: 33617940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The carcinogenic potential of nanomaterials, their release from products and options for regulating them.
    Becker H; Herzberg F; Schulte A; Kolossa-Gehring M
    Int J Hyg Environ Health; 2011 Jun; 214(3):231-8. PubMed ID: 21168363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of nanomaterials in food and consumer products: bridging the gap from legislation to enforcement.
    Stamm H; Gibson N; Anklam E
    Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2012 Aug; 29(8):1175-82. PubMed ID: 22725966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Minderoo-Monaco Commission on Plastics and Human Health.
    Landrigan PJ; Raps H; Cropper M; Bald C; Brunner M; Canonizado EM; Charles D; Chiles TC; Donohue MJ; Enck J; Fenichel P; Fleming LE; Ferrier-Pages C; Fordham R; Gozt A; Griffin C; Hahn ME; Haryanto B; Hixson R; Ianelli H; James BD; Kumar P; Laborde A; Law KL; Martin K; Mu J; Mulders Y; Mustapha A; Niu J; Pahl S; Park Y; Pedrotti ML; Pitt JA; Ruchirawat M; Seewoo BJ; Spring M; Stegeman JJ; Suk W; Symeonides C; Takada H; Thompson RC; Vicini A; Wang Z; Whitman E; Wirth D; Wolff M; Yousuf AK; Dunlop S
    Ann Glob Health; 2023; 89(1):23. PubMed ID: 36969097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A European nano-registry as a reliable database for quantitative risk assessment of nanomaterials? A comparison of national approaches.
    Pavlicek A; Part F; Rose G; Praetorius A; Miernicki M; Gazsó A; Huber-Humer M
    NanoImpact; 2021 Jan; 21():100276. PubMed ID: 35559789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measuring nanoparticles size distribution in food and consumer products: a review.
    Calzolai L; Gilliland D; Rossi F
    Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2012 Aug; 29(8):1183-93. PubMed ID: 22725833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Towards a more effective and efficient governance and regulation of nanomaterials.
    Teunenbroek TV; Baker J; Dijkzeul A
    Part Fibre Toxicol; 2017 Dec; 14(1):54. PubMed ID: 29258600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights into possibilities for grouping and read-across for nanomaterials in EU chemicals legislation.
    Mech A; Rasmussen K; Jantunen P; Aicher L; Alessandrelli M; Bernauer U; Bleeker EAJ; Bouillard J; Di Prospero Fanghella P; Draisci R; Dusinska M; Encheva G; Flament G; Haase A; Handzhiyski Y; Herzberg F; Huwyler J; Jacobsen NR; Jeliazkov V; Jeliazkova N; Nymark P; Grafström R; Oomen AG; Polci ML; Riebeling C; Sandström J; Shivachev B; Stateva S; Tanasescu S; Tsekovska R; Wallin H; Wilks MF; Zellmer S; Apostolova MD
    Nanotoxicology; 2019 Feb; 13(1):119-141. PubMed ID: 30182766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NanoDefiner Framework and e-Tool Revisited According to the European Commission's Nanomaterial Definition 2022/C 229/01.
    Brüngel R; Rückert J; Müller P; Babick F; Friedrich CM; Ghanem A; Hodoroaba VD; Mech A; Weigel S; Wohlleben W; Rauscher H
    Nanomaterials (Basel); 2023 Mar; 13(6):. PubMed ID: 36985884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanotechnology: the next big thing, or much ado about nothing?
    Maynard AD
    Ann Occup Hyg; 2007 Jan; 51(1):1-12. PubMed ID: 17041243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory aspects of nanotechnology in the agri/feed/food sector in EU and non-EU countries.
    Amenta V; Aschberger K; Arena M; Bouwmeester H; Botelho Moniz F; Brandhoff P; Gottardo S; Marvin HJ; Mech A; Quiros Pesudo L; Rauscher H; Schoonjans R; Vettori MV; Weigel S; Peters RJ
    Regul Toxicol Pharmacol; 2015 Oct; 73(1):463-76. PubMed ID: 26169479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limits and prospects of the "incremental approach" and the European legislation on the management of risks related to nanomaterials.
    Franco A; Hansen SF; Olsen SI; Butti L
    Regul Toxicol Pharmacol; 2007 Jul; 48(2):171-83. PubMed ID: 17509740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The current application of nanotechnology in food and agriculture.
    He X; Deng H; Hwang HM
    J Food Drug Anal; 2019 Jan; 27(1):1-21. PubMed ID: 30648562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The SCCS scientific advice on the safety of nanomaterials in cosmetics.
    ; Bernauer U; Bodin L; Chaudhry Q; Coenraads PJ; Dusinska M; Gaffet E; Panteri E; Rogiers V; Rousselle C; Stepnik M; Vanhaecke T; Wijnhoven S; ; von Goetz N; de Jong WH
    Regul Toxicol Pharmacol; 2021 Nov; 126():105046. PubMed ID: 34560169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative assessment of nanomaterial definitions and safety evaluation considerations.
    Boverhof DR; Bramante CM; Butala JH; Clancy SF; Lafranconi M; West J; Gordon SC
    Regul Toxicol Pharmacol; 2015 Oct; 73(1):137-50. PubMed ID: 26111608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Taking stock of the occupational safety and health challenges of nanotechnology: 2000-2015.
    Schulte PA; Roth G; Hodson LL; Murashov V; Hoover MD; Zumwalde R; Kuempel ED; Geraci CL; Stefaniak AB; Castranova V; Howard J
    J Nanopart Res; 2016 Jun; 18():159. PubMed ID: 27594804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The hierarchy of environmental health and safety practices in the U.S. nanotechnology workplace.
    Engeman CD; Baumgartner L; Carr BM; Fish AM; Meyerhofer JD; Satterfield TA; Holden PA; Harthorn BH
    J Occup Environ Hyg; 2013; 10(9):487-95. PubMed ID: 23927041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.